{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-318844","form_type":"8-K","ticker":"ALKS","cik":"0001520262","company_name":"Alkermes plc.","filed_at":"2026-07-28T11:05:18+00:00","discovered_at":"2026-07-28T11:10:00.372615+00:00","generated_at":"2026-07-28T11:10:40.387729+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Alkermes Q2 rev $496M, GAAP net income $0.5M; CEO transition to Blair Jackson Aug 1; guidance lowered on CVR charge","bullets":["Q2 2026 total revenues $496.0M; GAAP net income $0.5M; adjusted EBITDA $139.2M.","Blair Jackson to become CEO on Aug 1, 2026; Richard Pops remains Chairman.","Updated 2026 GAAP net loss guidance widened to ($95M)-($115M) from ($70M)-($90M) due to $26.4M CVR fair value increase.","LUMRYZ net sales $96.6M in Q2, including ~$7M inventory benefit; phase 3 idiopathic hypersomnia data positive.","Cash and investments $691.6M at June 30, 2026, up from $538.2M at March 31, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-318844","json":"https://secwatch.observer/filing/0001193125-26-318844.json","markdown":"https://secwatch.observer/filing/0001193125-26-318844.md","text":"https://secwatch.observer/filing/0001193125-26-318844.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1520262/000119312526318844/0001193125-26-318844-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1520262/000119312526318844/alks-20260728.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-28T11:10:40.387729+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}